Lixisenatide is under clinical development by Sanofi and currently in Phase II for Parkinson’s Disease. According to GlobalData, Phase II drugs for Parkinson’s Disease have a 41% phase transition ...

To most lay people, the acronym PBM means nothing. But PBMs serve as key intermediaries at the center of the complex and often opaque U.S. pharmaceutical distribution chain. Most Americans’ pres ...

The bill would bar drug intermediaries from owning pharmacies in the state. Speaking at the State Capitol Thursday, Moore said he wants Arkansas to lead a nationwide reform of PBM practices. “For far ...

That 2% slice of the rebate cash flow now gives drug manufacturers and other PBM critics a tool they can use to attack PBMs and confuse the public about why U.S. prescription drugs cost so much ...

Recent legislation aimed at reforming PBM practices, including transparency and decoupling their compensation from drug rebates was scrapped after opposition from President-elect Donald Trump's allies ...

The Federal Trade Commission (“FTC”) released its second interim report on Jan. 14, 2025, accusing pharmacy benefit managers (PBMs) of marking up the prices of specialty generic drugs.

The PBM's 41-page lawsuit says allowing the FTC's case to play out as an administrative proceeding overseen by an administrative law judge "would subvert bedrock constitutional principles of ...

The price concessions from the pharmacy come from lower contracted rates that pharmacies must accept in order to participate in the PBM’s pharmacy network. Depending on the way an employer ...

The FTC’s investigation into PBM practices began in 2022. Last summer, the agency released a scathing interim report on the industry. It detailed how increasing concentration enabled the three ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...